Belém Sampaio-Marques

Dr. Belém Sampaio-Marques

Inflammation, Cell Signaling and Therapeutics (InflamSignal), Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 August 2010 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
AMAna Mesquita
Ana Mesquita
MWMartin Weinberger
Martin Weinberger
ASAlexandra Silva
Alexandra Silva
BSBelém Sampaio-Marques
Belém Sampaio-Marques
BABruno Almeida
Bruno Almeida
Paula LudovicoPaula Ludovico
Paula Ludovico
The free radical theory of aging posits oxidative damage to macromolecules as a primary determinant of lifespan. Recent studies challenge this theory by demonstrating that in some cases, longevity is enhanced by inactivation of oxidative stress defenses or is correlated with increased, rather than decreased reactive oxygen species and oxidative damage. Here we show that, in Saccharomyces cerevisiae , caloric restriction or inactivation of catalases extends chronological lifespan by inducing elevated levels of the reactive oxygen species hydrogen peroxide, which activate superoxide dismutases that inhibit the accumulation of superoxide anions. Increased hydrogen peroxide in catalase-deficient cells extends chronological lifespan despite parallel increases in oxidative damage. These findings establish a role for hormesis effects of hydrogen peroxide in promoting longevity that have broad implications for understanding aging and age-related diseases.

15 November 2018 in Cell Death & Differentiation
Verified
Journal Article
Closed access
PDF file
JSJoana Silva
Joana Silva
SRSara Rodrigues
Sara Rodrigues
BSBelém Sampaio-Marques
Belém Sampaio-Marques
PGPatrícia Gomes
Patrícia Gomes
ANAndreia Neves-Carvalho
Andreia Neves-Carvalho
ISIoannis Sotiropoulos
Ioannis Sotiropoulos

16 October 2012 in Autophagy
Verified
Journal Article
Closed access
BSBelém Sampaio-Marques
Belém Sampaio-Marques
CFCarolina Felgueiras
Carolina Felgueiras
ASAlexandra Silva
Alexandra Silva
MRMárcio Rodrigues
Márcio Rodrigues
Sandra TenreiroSandra Tenreiro
Sandra Tenreiro
Paula LudovicoPaula Ludovico
Paula Ludovico
SNCA (α-synuclein) misfolding and aggregation is strongly associated with both idiopathic and familial forms of Parkinson disease (PD). Evidence suggests that SNCA has an impact on cell clearance r...

15 September 2007 in Journal of Cell Science
Verified
Journal Article
Open access
PDF file
BABruno Almeida
Bruno Almeida
SBSabrina Büttner
Sabrina Büttner
SOSteffen Ohlmeier
Steffen Ohlmeier
ASAlexandra Silva
Alexandra Silva
AMAna Mesquita
Ana Mesquita
Paula LudovicoPaula Ludovico
Paula Ludovico
Nitric oxide (NO) is a small molecule with distinct roles in diverse physiological functions in biological systems, among them the control of the apoptotic signalling cascade. By combining proteomic, genetic and biochemical approaches we demonstrate that NO and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are crucial mediators of yeast apoptosis. Using indirect methodologies and a NO-selective electrode, we present results showing that H2O2-induced apoptotic cells synthesize NO that is associated to a nitric oxide synthase (NOS)-like activity as demonstrated by the use of a classical NOS kit assay. Additionally, our results show that yeast GAPDH is a target of extensive proteolysis upon H2O2-induced apoptosis and undergoes S-nitrosation. Blockage of NO synthesis with Nω-nitro-L-arginine methyl ester leads to a decrease of GAPDH S-nitrosation and of intracellular reactive oxygen species (ROS) accumulation, increasing survival. These results indicate that NO signalling and GAPDH S-nitrosation are linked with H2O2-induced apoptotic cell death. Evidence is presented showing that NO and GAPDH S-nitrosation also mediate cell death during chronological life span pointing to a physiological role of NO in yeast apoptosis.

24 August 2019 in Cells
Verified
Journal Article
Open access
PDF file
ICIsabel Castro
Isabel Castro
BSBelém Sampaio-Marques
Belém Sampaio-Marques
Paula LudovicoPaula Ludovico
Paula Ludovico
The cancer metabolic reprogramming allows the maintenance of tumor proliferation, expansion and survival by altering key bioenergetics, biosynthetic and redox functions to meet the higher demands of tumor cells. In addition, several metabolites are also needed to perform signaling functions that further promote tumor growth and progression. These metabolic alterations have been exploited in different cancers, including acute myeloid leukemia, as novel therapeutic strategies both in preclinical models and clinical trials. Here, we review the complexity of acute myeloid leukemia (AML) metabolism and discuss how therapies targeting different aspects of cellular metabolism have demonstrated efficacy and how they provide a therapeutic window that should be explored to target the metabolic requirements of AML cells.

9 May 2017 in Molecular Psychiatry
Verified
Journal Article
Closed access
AFA C Ferreira
A C Ferreira
TSTiago Santos
Tiago Santos
BSBelém Sampaio-Marques
Belém Sampaio-Marques
ANAshley Novais
Ashley Novais
SMSandro Dá Mesquita
Sandro Dá Mesquita
FMF Marques
F Marques